Influence of dehydroepiandrosterone and 5-en-androstene-3 beta, 17 beta-diol on the growth of MCF-7 human breast cancer cells induced by 17 beta-estradiol
- PMID: 1535770
Influence of dehydroepiandrosterone and 5-en-androstene-3 beta, 17 beta-diol on the growth of MCF-7 human breast cancer cells induced by 17 beta-estradiol
Abstract
The effects of dehydroepiandrosterone (DHEA) and 5-en-androstene-3 beta, 17 beta-diol (ADIOL) on the proliferation of MCF-7 cells were studied both in steroid - free and estradiol (E2) supplemented media. Growth was evaluated by counting the cells after six days of culture. The results show that DHEA 500 nM and ADIOL 2 nM stimulate MCF-7 cell growth in steroid-free medium, while in medium supplemented with E2 1 nM they partly antagonize the stimulatory effect of the estrogen. The latter action is also shown by lower DHEA concentrations (20 nM, 100 nM), which have no effect when added to the steroid-free medium. Incubations carried out in the presence of labeled DHEA show its conversion to ADIOL. Moreover, tamoxifen counteracts in a dose-depended manner the stimulatory effect of DHEA and ADIOL, suggesting that it is mediated by an interaction with estrogen receptors.
Similar articles
-
Stimulation of cell proliferation and estrogenic response by adrenal C19-delta 5-steroids in the ZR-75-1 human breast cancer cell line.Cancer Res. 1986 Oct;46(10):4933-7. Cancer Res. 1986. PMID: 2944574
-
Estrogenic effects of physiological concentrations of 5-androstene-3 beta, 17 beta-diol and its metabolism in MCF7 human breast cancer cells.Cancer Res. 1981 Nov;41(11 Pt 1):4720-6. Cancer Res. 1981. PMID: 6458355
-
Dehydroepiandrosterone antiestrogenic action through androgen receptor in MCF-7 human breast cancer cell line.Anticancer Res. 1993 Nov-Dec;13(6A):2267-72. Anticancer Res. 1993. PMID: 8297144
-
Physiological importance of dehydroepiandrosterone.Lancet. 1994 Jun 11;343(8911):1479-81. doi: 10.1016/s0140-6736(94)92587-9. Lancet. 1994. PMID: 7911183 Review.
-
Dehydroepiandrosterone (DHEA)--the multifunctional steroid. II. Effects on the CNS, cell proliferation, metabolic and vascular, clinical and other effects. Mechanism of action?Ann N Y Acad Sci. 1994 May 31;719:564-75. doi: 10.1111/j.1749-6632.1994.tb56860.x. Ann N Y Acad Sci. 1994. PMID: 8010624 Review. No abstract available.
Cited by
-
Dehydroepiandrosterone and diseases of aging.Drugs Aging. 1996 Oct;9(4):274-91. doi: 10.2165/00002512-199609040-00005. Drugs Aging. 1996. PMID: 8894525 Review.
-
Phase II Study of Dehydroepiandrosterone in Androgen Receptor-Positive Metastatic Breast Cancer.Oncologist. 2019 Jun;24(6):743-e205. doi: 10.1634/theoncologist.2018-0243. Epub 2018 Dec 27. Oncologist. 2019. PMID: 30591548 Free PMC article. Clinical Trial.
-
Computational Cell Cycle Profiling of Cancer Cells for Prioritizing FDA-Approved Drugs with Repurposing Potential.Sci Rep. 2017 Sep 12;7(1):11261. doi: 10.1038/s41598-017-11508-2. Sci Rep. 2017. PMID: 28900159 Free PMC article.
-
Dehydroepiandrosterone inhibits events related with the metastatic process in breast tumor cell lines.Cancer Biol Ther. 2016 Sep;17(9):915-24. doi: 10.1080/15384047.2016.1195047. Epub 2016 Jun 3. Cancer Biol Ther. 2016. PMID: 27260851 Free PMC article.
-
Flavonoid Intake and Plasma Sex Steroid Hormones, Prolactin, and Sex Hormone-Binding Globulin in Premenopausal Women.Nutrients. 2019 Nov 5;11(11):2669. doi: 10.3390/nu11112669. Nutrients. 2019. PMID: 31694190 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Research Materials